Financials data is unavailable for this security.
View more
Year on year Dalian BIO-CHEM Co Ltd 's revenues fell -15.20% from 1.26bn to 1.07bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 402.57m to 328.38m, a -18.43% decrease.
Gross margin | 45.11% |
---|---|
Net profit margin | 26.99% |
Operating margin | 31.12% |
Return on assets | 15.60% |
---|---|
Return on equity | 18.27% |
Return on investment | 17.86% |
More ▼
Cash flow in CNYView more
In 2023, Dalian BIO-CHEM Co Ltd increased its cash reserves by 19.73%, or 78.01m. The company earned 405.15m from its operations for a Cash Flow Margin of 38.02%. In addition the company used 126.92m on investing activities and also paid 188.16m in financing cash flows.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 3.36 |
---|---|
Tangible book value per share | 3.28 |
More ▼
Balance sheet in CNYView more
Current ratio | 5.07 |
---|---|
Quick ratio | 4.50 |
Total debt/total equity | 0.092 |
---|---|
Total debt/total capital | 0.0843 |
More ▼
Growth rates in CNY
Year on year, growth in dividends per share increased 5.00% while earnings per share excluding extraordinary items fell by -18.63%. The positive trend in dividend payments is noteworthy since only some companies in the Chemical Manufacturing industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg) | 3.12% |
---|---|
Div growth rate (5 year) | 24.70% |
Payout ratio (TTM) | 72.15% |
EPS growth(5 years) | 18.57 |
---|---|
EPS (TTM) vs TTM 1 year ago | -14.75 |
More ▼